Advanced Cell Technology, a Santa Monica, Calif.-based regenerative medicine company, is also working towards a macular degeneration treatment in two clinical trials recently approved by the FDA.
More Articles on Ophthalmology:
EyeTechCare Receives $13M in Funding
10 Statistics on Ophthalmologist Compensation by Location
Dr. Andrew Holzman to Participate in FDA Trial
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
